INSIGHTS ON DRUG DEVELOPMENT
-
How Solid-State Science Solves Your Toughest API Challenges
Difficult small molecules demand more than standard purification strategies. See how combining solid-state expertise with advanced chromatographic modeling improves filtration, purity, and scalability.
-
Microglia: Where We Came From And Where We Are Now
Gain expert insights into the evolution of microglia research and the future of this field, including the innovative tools being developed to investigate the role of microglia in health and disease.
-
How CRISPR And LNP Accelerate Therapeutic Innovation Through Analytics
CRISPR gene editing and lipid nanoparticle delivery are revolutionizing precision medicine. Discover how optimized LNP systems and advanced analytics accelerate therapeutic development.
-
A Digital Dispenser For Single-Cell And Low-Input Proteomics
Discover a high-precision dispensing system that enables rapid, low-volume sample prep for single-cell proteomics to support flexible workflows, maintain cell integrity, and deliver reliable results.
-
Producing Quality APIs At Scale5/7/2026
Targeted process optimization transformed an early‑phase API with yield and impurity challenges into a scalable, high‑quality manufacturing process ready to support ongoing drug development.
-
3D Neurospheres In Healthy And Alzheimer's: iPSC-Derived Neurons4/4/2025
Explore how different ApoE alleles influence Alzheimer's Disease risk using iPSC-derived neurons as well as gain insights into AD mechanisms and potential therapies.
-
T3P – A Green Solution For Peptide Coupling, Water Removal Reactions1/13/2026
The session focuses on the use of T3P (propanephosphonic acid anhydride) in amidation and peptide coupling reactions, including both liquid-phase and solid-phase peptide synthesis.
-
Can Collaboration Close Biopharma's Talent Gap For Good?3/17/2026
Biopharma innovation is accelerating, but workforce shortages threaten progress. See how strengthening collaboration is essential to developing the skills needed for emerging therapies.
-
Evaluating Compound Toxicity Effects On Healthy Intestinal Organoids3/24/2025
3D organoids enhance drug toxicity prediction and are crucial for anti-cancer drug development. Examine a method using 3D mouse intestinal organoids that aims to provide vital data on intestinal toxicity.
DRUG DEVELOPMENT SOLUTIONS
-
The commercialization of a combination product can be a complex process that involves obtaining the proper data, choosing a drug delivery system, developing a regulatory strategy and conducting clinical trials—all of which can increase development risks and affect your molecule’s time to market.
-
This pipeline outlines a sequence of late‑stage and emerging therapeutics projected to launch between 2024 and 2031, spanning immunology, neurology, psychiatry, rare disease, oncology, and inflammatory disorders.
-
Rapid, high-throughput IgG quantification assay. Available in 96 & 384-well microplate options.
-
S APO Greenough Stereo Microscope
Save up to 20% inspection and rework time*
Continuously improving production, keeping defect rates low, and fulfilling customer requests in order to stay competitive can be very challenging. Leica has developed the S9 stereo microscope series to help you cope with these challenges. With this generation of Greenough stereo microscopes operators will be able to reveal details faster as they spend less time having to adjust the microscope.
*compared to the standard industrial stereo microscope S6 from Leica
-
When it comes to solid dosage formulations, the most common challenge formulators face is poor solubility. In numbers: 70% of drugs in development are poorly soluble.